Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism.
Maroufi NF, Vahedian V, Mazrakhondi SAM, Kooti W, Khiavy HA, Bazzaz R, Ramezani F, Pirouzpanah SM, Ghorbani M, Akbarzadeh M, Hajipour H, Ghanbarzadeh S, Sabzichi M. Maroufi NF, et al. Among authors: ghorbani m. Naunyn Schmiedebergs Arch Pharmacol. 2020 Jan;393(1):1-11. doi: 10.1007/s00210-019-01692-5. Epub 2019 Aug 2. Naunyn Schmiedebergs Arch Pharmacol. 2020. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 10. doi: 10.1007/s00210-024-03709-0 PMID: 31372697 Retracted.
Nanovehicles for co-delivery of anticancer agents.
Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR. Zeinali M, et al. Among authors: ghorbani m. Drug Discov Today. 2020 Aug;25(8):1416-1430. doi: 10.1016/j.drudis.2020.06.027. Epub 2020 Jul 2. Drug Discov Today. 2020. PMID: 32622880 Review.
Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism.
Ahmadian S, Sabzichi M, Rashidi M, Mohammadian J, Mahmoudi S, Maroufi NF, Ramezani F, Ghorbani M, Mohammadi M, Pirouzpanah M, Bijanpour H. Ahmadian S, et al. Among authors: ghorbani m. Naunyn Schmiedebergs Arch Pharmacol. 2021 Jul;394(7):1521-1528. doi: 10.1007/s00210-021-02079-1. Epub 2021 Mar 18. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 33735393
Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer cells.
Sabzichi M, Oladpour O, Mohammadian J, Rashidi M, Hosseinzadeh M, Mardomi A, Ramezani B, Ghorbani M, Ramezani F. Sabzichi M, et al. Among authors: ghorbani m. Naunyn Schmiedebergs Arch Pharmacol. 2021 Dec;394(12):2429-2439. doi: 10.1007/s00210-021-02164-5. Epub 2021 Sep 30. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34590187
Retraction Note: Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism.
Maroufi NF, Vahedian V, Mazrakhondi SAM, Kooti W, Khiavy HA, Bazzaz R, Ramezani F, Pirouzpanah SM, Ghorbani M, Akbarzadeh M, Hajipour H, Ghanbarzadeh S, Sabzichi M. Maroufi NF, et al. Among authors: ghorbani m. Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 10. doi: 10.1007/s00210-024-03709-0. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39656224 No abstract available.
782 results